Search over 3,000 reports

    Loestrin 24 Fe- Drug Insights, 2017

    Loestrin 24 Fe- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0190
    DelveInsight's pharmaceuticals report, " Loestrin 24 Fe Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Loestrin 24 Fe covering the historical global sales and also provides the Loestrin 24 Fe sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Loestrin 24 Fe and emerging therapies in this space.

    Scope

    A review of the Loestrin 24 Fe, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Loestrin 24 Fe- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Pharmacology
    Pharmacodynamics
    Pharmacokinetics
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Loestrin 24 Fe Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1: Loestrin 24 Fe, Description
    Table 2: Loestrin 24 Fe, Product Details
    Table 3: Loestrin 24 Fe, Historical Sales (in million USD)
    Table 4: Loestrin 24 Fe, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Loestrin 24 Fe, Patent Details
    Table 6: Company, Overview
    Table 7: Loestrin 24 Fe Major Competitors Loestrin 24 Fe
    Table 8: Emerging Therapies
    Figure 1: Loestrin 24 Fe, Historical Sales (in million USD)
    Figure 2: Loestrin 24 Fe, Forecasted Sales from 2017-2019 (in million USD)
    Loestrin 24 Fe
    Warner Chilcott
    prevention of pregnancy
    birth control
    Loestrin 24 Fe Marketed Drugs Overview
    Loestrin 24 Fe Market Assessment
    Loestrin 24 Fe API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Loestrin 24 Fe US DMF
    Loestrin 24 Fe US Drug Master Files
    Loestrin 24 Fe Active Substance Master File/ EUDMF
    Loestrin 24 Fe Generic players
    Loestrin 24 Fe Patent Expiration
    Loestrin 24 Fe Patent Exclusivity
    Loestrin 24 Fe API Manufacturers
    Loestrin 24 Fe Global Forecasted Sales Figure
    Loestrin 24 Fe API Route of Synthesis
    Loestrin 24 Fe Market sales
    Loestrin 24 Fe SWOT Analysis
    Loestrin 24 Fe Pipeline
    • Single User License
      (20% Off)
      $1,000.00
      $800
    • Site License
      (30% Off)
      $2,000.00
      $1400
    • Global License
      (40% Off)
      $3,000.00
      $1800

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap